The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2026

Filed:

Nov. 11, 2025
Applicant:

Revascardio Ltd., Ra'anana, IL;

Inventors:

Shahaf Marmor, Tel Aviv, IL;

Oded Meiri, Ram-On, IL;

Assaf Alon, Elkana, IL;

Chaim Zeev Aber, Ra'anana, IL;

David Shlomo Chayen, Tel Aviv, IL;

Assignee:

REVASCARDIO LTD., Ra'anana, IL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 17/12 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61B 90/00 (2016.01); A61M 27/00 (2006.01);
U.S. Cl.
CPC ...
A61B 17/12036 (2013.01); A61B 17/00234 (2013.01); A61B 17/12122 (2013.01); A61B 17/12172 (2013.01); A61B 17/34 (2013.01); A61B 90/06 (2016.02); A61M 27/002 (2013.01); A61B 2017/00022 (2013.01); A61B 2017/00252 (2013.01); A61B 2090/064 (2016.02); A61M 2205/04 (2013.01); A61M 2205/3331 (2013.01); A61M 2210/125 (2013.01);
Abstract

Devices, systems, and methods for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium are disclosed. Devices and methods include a method for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium, the method comprising: implanting a variable occluder in a coronary sinus region proximate a left atrium, wherein the variable occluder is configured to gradually increase a level of blood flow restriction over a period of days to enable a venous system of the myocardium to compensate for increased pressure caused by the gradual increase in the level of blood flow restriction; and following venous system compensation, shunting oxygenated blood flow into the coronary sinus to cause retrograde flow of oxygenated blood in at least a portion of the venous system of the myocardium to thereby enable revascularization of the myocardium.


Find Patent Forward Citations

Loading…